Our Firm has not only filed numerous Xarelto lawsuits; we’ve also been actively monitoring updates that pertain to our clients.
(PRWEB) March 08, 2015
Attorneys at Bernstein Liebhard LLP are awaiting an upcoming status conference in the federal litigation established for Xarelto lawsuits (http://www.xareltolawsuit2015.com/), where the Firm has claims pending.
A Calendar posted on the Court’s website indicates that the monthly meeting has been scheduled for April 1, 2015 at 9:00 a.m., and will take place in the U.S. District Court, Eastern District of Louisiana. Among the items listed on the Court’s agenda will be a discussion of lawsuits that allege life-threatening internal bleeding episodes caused by the anticoagulant, and other complications. Users claim they were inadequately warned about by the drug’s manufacturers, Bayer Healthcare and the Johnson & Johnson subsidiary, Janssen Pharmaceuticals. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Since this litigation was established in December 2014, our Firm has not only filed numerous Xarelto lawsuits; we’ve also been actively monitoring updates that pertain to our clients. We are looking forward to information that may be discussed at the proceeding’s status conference in April,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits on behalf of individuals who allegedly suffered a life-threatening internal bleeding episode, a stroke, deep vein thrombosis or pulmonary embolism caused by the anticoagulant.
With more than 220 Xarelto lawsuits now pending in the U.S. District Court, Eastern District of Louisiana, parties involved in the blood thinner litigation will likely have a lot to discuss at its April status conference. The proceeding was created in December 2014 after a federal panel transferred several similar cases to the Court.
Plaintiffs involved in Xarelto lawsuits that were filed by Bernstein Liebhard LLP and other Firms involved in the Louisiana litigation allege episodes of uncontrollable internal bleeding, as well as strokes, deep vein thrombosis, pulmonary embolism, and other complications they claim to have been inadequately warned about. Plaintiffs further allege that Janssen and Bayer have been improperly marketing Xarelto as a convenient alternative to warfarin, a decades-old alternative, since it received U.S. market clearance in 2011. They further claim that the companies fail to fully tell consumers that there is no available reversal agent to stop Xarelto bleeding episodes once they begin, which may increase a patient’s risk for death. Warfarin is also associated with this complication, but the lawsuits point out that those episodes can be stopped with the administration of Vitamin K.
Xarelto patients who allegedly experienced internal bleeding episodes caused by the blood thinner may be entitled to compensation for out-of-pocket medical expenses, lost wages, pain and suffering and other damages. Learn more about the risk for Xarelto internal bleeding when you visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP